about
Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer.Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trialInsular organization of gene space in grass genomes.Optimal recall period for caregiver-reported illness in risk factor and intervention studies: a multicountry study.A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancieLocal difference measures between complex networks for dynamical system model evaluation.Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study.Using null models to infer microbial co-occurrence networks.Lapatinib and potential prognostic value of EGFR mutations in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancerA Framework for Assessing Broad Sense Agreement Between Ordinal and Continuous MeasurementsAssessing the statistical significance of the achieved classification error of classifiers constructed using serum peptide profiles, and a prescription for random sampling repeated studies for massive high-throughput genomic and proteomic studies.A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a gynecologic oncology group study.A new closeness centrality measure via effective distance in complex networks.Stuart's tau measure of effect size for ordinal variables: some methodological considerations.Concordance between ratings using different scales for the same variable.Calcitonin Response to Naturally Occurring Ionized Hypercalcemia in Cats with Chronic Kidney Disease.An Experimental Exploration of Marsaglia's xorshift Generators, ScrambledFocused scores enable reliable discrimination of small differences in steatosisA measure of identifying influential waypoints in air route networksIdentification of influential spreaders in complex networks using HybridRank algorithm
P2860
Q30497303-647E9D58-00B2-4988-A932-82A172F38514Q30505345-98CEA0AC-607B-499B-AB2B-E2DC9716E84DQ34552145-0BF99433-5B2D-4E85-8F69-786FB977A76EQ34567988-38DCB212-A240-403B-A9B2-5D1EFE72588DQ35000494-57F53B51-A789-4D8A-8B80-786492317BABQ35346007-BC63875F-25A2-4CCC-9ECD-D6CF02D6F204Q35913613-96FAFB81-98D5-4B44-8A37-F5569250EC35Q36369015-17B19554-D176-443E-9143-0D249EA1C375Q36456386-994D6050-3AE8-4E14-8E4C-681668B4B0BDQ36590368-622B916D-E116-4441-A0BA-387EB5B444BBQ37133375-9C5570F6-EC14-464F-95B3-379BDCD4A8F6Q37677618-E04232B2-B335-40EB-B40D-07CB63547FDEQ41361942-9B17DCB2-CD06-4AB3-964F-D5F4E403ED30Q47586897-B63B7F00-F68D-4058-8723-B1F2D553D61DQ52069976-7FF92584-0BA9-44EB-AF4E-EE161DFB32B0Q52690407-40F38CF6-1B44-43B1-9C91-EBD42BC711ACQ56081879-9C0A24E6-7145-48B9-A542-FBE787530BF5Q58084446-A82214ED-D7CC-4057-9E31-9BA9D8083535Q58727308-9674928C-F3E8-4D7A-B170-8E70666B38E0Q58793841-DB7F252E-B180-4A4A-8115-3AAE2CEECE4D
P2860
description
1945 nî lūn-bûn
@nan
1945年の論文
@ja
1945年学术文章
@wuu
1945年学术文章
@zh-cn
1945年学术文章
@zh-hans
1945年学术文章
@zh-my
1945年学术文章
@zh-sg
1945年學術文章
@yue
1945年學術文章
@zh
1945年學術文章
@zh-hant
name
The treatment of ties in ranking problems.
@en
The treatment of ties in ranking problems.
@nl
type
label
The treatment of ties in ranking problems.
@en
The treatment of ties in ranking problems.
@nl
prefLabel
The treatment of ties in ranking problems.
@en
The treatment of ties in ranking problems.
@nl
P356
P1433
P1476
The treatment of ties in ranking problems.
@en
P2093
KENDALL MG
P304
P356
10.1093/BIOMET/33.3.239
P407
P577
1945-11-01T00:00:00Z